Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation.
SourceArteriosclerosis, Thrombosis, and Vascular Biology, 24, 2, (2004), pp. 301-307
Article / Letter to editor
Display more detailsDisplay less details
Arteriosclerosis, Thrombosis, and Vascular Biology
SubjectUMCN 5.1: Genetic defects of metabolism
OBJECTIVE: Betaine is a substrate in the betaine-homocysteine methyltransferase reaction, converting homocysteine to methionine. There are only sparse data on plasma betaine as a determinant of the plasma total homocysteine (tHcy) concentration. METHODS AND RESULTS: Ninety patients undergoing coronary angiography were randomized into 4 groups administered oral: (1) folic acid (0.8 mg), vitamin B12 (0.4 mg), and vitamin B6 (40 mg); (2) folic acid and vitamin B12; (3) vitamin B6 alone; or (4) placebo. Nonfasting blood samples were collected at baseline and 3, 14, and 28 days and 3, 6, and 12 months after treatment start. A 4-hour methionine-loading test (0.1 g/kg) was performed at baseline and after 3 months. At baseline, median (interquartile range) plasma betaine was 36.9 micromol/L (range: 30.3 to 46.8) and was increased by 15% after methionine loading. The postmethionine load (PML) increase in tHcy was inversely related to plasma betaine (beta=-0.29, P=0.02) and even more strongly to PML betaine (beta=-0.47, P<0.001). After 3 months of intervention, the relation between the PML increase in tHcy and PML betaine was weakened (beta=-0.33, P=0.007). CONCLUSIONS: Plasma betaine is a strong determinant of the PML increase in tHcy in subjects not supplemented with B-vitamins.
This item appears in the following Collection(s)
- Non RU Publications 
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.